Aspira Women’s Health (NASDAQ:AWH – Get Free Report) announced its earnings results on Thursday. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.13, Zacks reports.
Aspira Women’s Health Trading Up 5.8 %
NASDAQ:AWH opened at $0.11 on Friday. The firm has a market capitalization of $1.94 million, a PE ratio of -0.09 and a beta of 1.57. The stock has a 50 day moving average of $0.26 and a 200-day moving average of $0.61. Aspira Women’s Health has a 52 week low of $0.08 and a 52 week high of $3.68.
Wall Street Analysts Forecast Growth
Separately, StockNews.com assumed coverage on Aspira Women’s Health in a report on Sunday, January 12th. They issued a “hold” rating for the company.
Aspira Women’s Health Company Profile
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Further Reading
- Five stocks we like better than Aspira Women’s Health
- Basic Materials Stocks Investing
- Microsoft’s Big Malaysia Bet Could Pay Off for Investors
- High Dividend REITs: Are They an Ideal Way to Diversify?
- The 5 Most Oversold Stocks on the Market Are…
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Archer Aviation Stock Sees Surge in Institutional Buys
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.
